The Community Oncology Alliance (COA), a US non-profit organization, announced the results of a drug shortage survey of 200 member practices representing 525 physicians across the USA. 98.9% of the respondents reported experiencing a drug shortage in the last year.
Survey participants indicated that the cancer progressed more quickly in more than 60% of patients as a result of the drug shortages, and more than 70% of patients had more severe side effects as a result of drug shortages.
Almost half of those surveyed reported seeing more than one patient per day affected by a drug shortage and 58.2% indicate the shortage in cancer care drugs is increasing. Over 80% of the patients and over 90% of the practices affected by a cancer drug shortage also experienced a more severe financial burden.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze